CLINICAL FEATURES, LABORATORY CHARACTERISTICS, ANTIBIOTIC SUSCEPTIBILITIES OF KLEBSIELLA PNEUMONIAE CAUSING COMMUNITY-ACQUIRED SEPSIS
Main Article Content
Abstract
Objectives: Describe the clinical, laboratory characteristics and antibiotic susceptibilities of patients with community-acquired sepsis due to Klebsiella pneumoniae treated at the National Hospital of Tropical Diseases from 2018 to 2023. Participants and Methods: A cross-sectional descriptive study involving 102 patients diagnosed with sepsis caused by K. pneumoniae. Results: The average age of the patients studied was 54.82 ± 12.8 years old. Common underlying conditions included diabetes (46.1%), cirrhosis (29.4%), and hypertension (25.5%). All patients had fever, the nature of the fever was usually chills (68.6%). Commonly infected organs are digestive symstem (59.8%), respiratory symstem (29.4%) and central nervous symstem (29.6%). Regular blood tests upon hospitalization showed thrombocytopenia (< 150 G/L) in 61.8% of cases, with an average leukocyte count of 12.7 ± 6.3 G/L. Coagulation disorders were observed in patients. 61.8% of cases increase total bilirubin > 17 µmol/L, 75.3% decrease albumin < 35 g/L, increase AST and ALT in over 70% of cases. Creatinine ≥ 120 µmol/L in 13.9% of patients. Most of patients increased infectious indices at high levels, CRP > 100 mg/L (78.0%) and PCT > 10 ng/ml (50.9%). We recorded an increase in drug resistance of K. pneumoniae in the study, especially, 7% of cases were resistant to carbapenem compared to previous studies. Conclusion: Community-acquired sepsis due to K. pneumoniae predominantly affects individuals elderly with underlying health conditions, leading to multi-organ dysfunction. The prevalence of antibiotic-resistant K. pneumoniae in the community is on the rise.
Article Details
References
2. Logan LK, Weinstein RA. 2017. The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace. The Journal of Infectious Diseases. 2017 Feb 15;215(suppl_1):S28–36.
3. Hương NL, Hùng TM, Nam LV. 2021. Đặc điểm lâm sàng, cận lâm sàng của bệnh nhân nhiễm khuẩn huyết do Klebsiella pneumoniae. VMJ. 2021 Oct 24;506(2).
4. Sơn TV, Mạnh NĐ, Song LH. 2020. Sự khác nhau giữa nhiễm khuẩn huyết do Escherichia coli và Klebsiella pneumoniae. Journal of 108 - Clinical Medicine and Phamarcy. 2020 Feb 20;
5. Ko WC. 2002. Community-Acquired Klebsiella pneumoniae Bacteremia: Global Differences in Clinical Patterns. Emerg Infect Dis. 2002 Feb;8(2):160–6.
6. Phương NT. 2018. Nghiên cứu đặc điểm lâm sàng, cận lâm sàng và tình trạng kháng kháng sinh của vi khuẩn Klebsiella ở bệnh nhân nhiễm khuẩn huyết (01/2015 - 6/2016). Tạp chí y - dược học quân sự. 2018;7.
7. Melot B, Colot J, Guerrier G. 2015. Bacteremic community-acquired infections due to Klebsiella pneumoniae: clinical and microbiological presentation in New Caledonia, 2008–2013. International Journal of Infectious Diseases. 2015 Dec 1;41:29–31.
8. Dat VQ, Vu HN, Nguyen The H, Nguyen HT, Hoang LB, Vu Tien Viet D, et al. 2017. Bacterial bloodstream infections in a tertiary infectious diseases hospital in Northern Vietnam: aetiology, drug resistance, and treatment outcome. BMC Infect Dis. 2017 Dec;17(1):493.